Vimarsana
Biggest News Aggregation in the World

Sandeep Sehdev News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sandeep Sehdev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sandeep Sehdev Today - Breaking & Trending Today

Sehdev: Let's help cancer patients get treatment without losing their jobs - Vimarsana News

Sehdev: Let's help cancer patients get treatment without losing their jobs

By changing the provincial Employment Standards Act, Ontario can remove a significant stress that faces many who are trying to recover.

Batist: We must speed drug approvals to fight diseases such as cancer - Vimarsana News

Batist: We must speed drug approvals to fight diseases such as cancer

We did it for COVID. So why do we still use demonstrably slow processes to test, review and OK effective treatments for lethal illnesses?

Opinion: We can, and must, speed up approval of life-saving drugs - Vimarsana News

Opinion: We can, and must, speed up approval of life-saving drugs

We did it for COVID. So why do we still use demonstrably slow processes to test, review and OK effective treatments for lethal illnesses?

Organon Canada launches Aybintio®, a biosimilar of the reference biologic Avastin®, providing a new option at a reduced cost for Canadians living with certain aggressive forms of cancer - Vimarsana News

Organon Canada launches Aybintio®, a biosimilar of the reference biologic Avastin®, providing a new option at a reduced cost for Canadians living with certain aggressive forms of cancer

/CNW/ - Organon (NYSE: OGN), a global women's health company, is announcing the launch and product availability of Aybintio®, a biosimilar of Avastin®,...

Slow government approval process for new treatments hurting breast cancer patients: experts - Vimarsana News

Slow government approval process for new treatments hurting breast cancer patients: experts

Experts say Canadian breast cancer patients are being held back on the latest technology for their care because of Canada's vigorous vetting process.